Surgepays is trading at $0.15, up +5.73%, with no verified company-specific announcement on October 27 explaining the move.
- The GrowthLine launch was announced October 15, not October 27.
- Surgepays rose during a broader technology-led market rally. The Nasdaq and S&P 500 rose while the Dow was nearly flat, but available evidence does not establish that the rally caused this after-hours move.